Results revealed that patients with type 2 diabetes, who were carriers of the HMGA1 rs139876191 variant had a significantly lower risk of developing PDR, compared to non-carrier diabetic patients. This evidence concerns the gene HMGA1 and type 2 diabetes mellitus.